BHC

SEC source: 0000885590-26-000113 · form4.xml · nonDerivative · entry 1

LEUNG SANDRA · CIK 0001199294 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,859

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000111 · form4.xml · nonDerivative · entry 1

WECHSLER AMY B · CIK 0001677300 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,158

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000115 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 440,962

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000109 · form4.xml · nonDerivative · entry 1

Lenar Aimee J. · CIK 0002029927 · President, US Pharma

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 334,853

F1 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 21, 2026.

SEC source: 0000885590-26-000101 · form4.xml · nonDerivative · entry 1

Lenar Aimee J. · CIK 0002029927 · President, US Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,680

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000099 · form4.xml · nonDerivative · entry 1

Lenar Aimee J. · CIK 0002029927 · President, US Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376,940

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000097 · form4.xml · nonDerivative · entry 1

LEE STEVEN HYOSIG · CIK 0001855708 · SVP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,114

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000093 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430,242

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000095 · form4.xml · nonDerivative · entry 1

WECHSLER AMY B · CIK 0001677300 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,979

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000091 · form4.xml · nonDerivative · entry 1

LEUNG SANDRA · CIK 0001199294 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,070

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000083 · form4.xml · nonDerivative · entry 1

WECHSLER AMY B · CIK 0001677300 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313,585

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

SEC source: 0000885590-26-000082 · form4.xml · nonDerivative · entry 1

ROBERTS EIRY · CIK 0001727606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,871

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

SEC source: 0000885590-26-000081 · form4.xml · nonDerivative · entry 1

POWER ROBERT N · CIK 0001187303 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,594

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

SEC source: 0000885590-26-000080 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 417,565

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

SEC source: 0000885590-26-000079 · form4.xml · nonDerivative · entry 1

LEUNG SANDRA · CIK 0001199294 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,225

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

SEC source: 0000885590-26-000078 · form4.xml · nonDerivative · entry 1

Lee Frank D. · CIK 0001814686 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,210

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

SEC source: 0000885590-26-000077 · form4.xml · nonDerivative · entry 1

KAVANAGH SARAH B · CIK 0001681171 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,230

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

SEC source: 0000885590-26-000076 · form4.xml · nonDerivative · entry 1

GOETTLER MICHAEL · CIK 0001745691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,020

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

SEC source: 0000885590-26-000075 · form4.xml · nonDerivative · entry 1

Garcia Christian A · CIK 0001527370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,578

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

SEC source: 0000885590-26-000063 · form4.xml · nonDerivative · entry 1

Lee Frank D. · CIK 0001814686 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,339

F1 · shares: Represents shares of the Issuer's common stock, no par value, sold in the open market pursuant to a Rule 10b5-1 trading plan to fund estimated tax obligations arising from a previously vested equity award granted to the Issuer's non-employee directors.

SEC source: 0000885590-26-000047 · form4.xml · nonDerivative · entry 1

LEUNG SANDRA · CIK 0001199294 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,354

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000045 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,694

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000043 · form4.xml · nonDerivative · entry 1

WECHSLER AMY B · CIK 0001677300 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,714

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 5

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 616,761

F5 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025.

SEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 4

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 621,181

F4 · shares: Reflects the disposition in cash as contemplated by paragraph 7(1)(b) of the Income Tax Act (Canada) of 137,922 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The disposition in cash is exempt under Rule 16b-3(e).

SEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 3

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 759,103

F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 2

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 776,076

F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025.

SEC source: 0000885590-26-000037 · form4.xml · nonDerivative · entry 3

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,315,374

F3 · shares: Reflects the settlement in cash of 1,137,862 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The settlement in cash is exempt under Rule 16b-3(e).

SEC source: 0000885590-26-000037 · form4.xml · nonDerivative · entry 2

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,453,236

F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000031 · form4.xml · nonDerivative · entry 3

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 809,258

F3 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 7, 2025.

SEC source: 0000885590-26-000041 · form4.xml · nonDerivative · entry 1

Charhon Jean-Jacques · CIK 0001725564 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 706,478

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 1

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 782,932

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000037 · form4.xml · nonDerivative · entry 1

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,536,941

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000033 · form4.xml · nonDerivative · entry 2

Lenar Aimee J. · CIK 0002029927 · EVP, US Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,335

F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000031 · form4.xml · nonDerivative · entry 2

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 817,646

F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000029 · form4.xml · nonDerivative · entry 2

Charhon Jean-Jacques · CIK 0001725564 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 755,538

F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000025 · form4.xml · nonDerivative · entry 2

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,620,034

F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

SEC source: 0000885590-26-000035 · form4.xml · nonDerivative · entry 1

LEE STEVEN HYOSIG · CIK 0001855708 · SVP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,239

F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

SEC source: 0000885590-26-000033 · form4.xml · nonDerivative · entry 1

Lenar Aimee J. · CIK 0002029927 · EVP, US Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 417,913

F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

SEC source: 0000885590-26-000031 · form4.xml · nonDerivative · entry 1

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 849,857

F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

SEC source: 0000885590-26-000029 · form4.xml · nonDerivative · entry 1

Charhon Jean-Jacques · CIK 0001725564 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 791,515

F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

SEC source: 0000885590-26-000025 · form4.xml · nonDerivative · entry 1

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,736,536

F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

SEC source: 0000885590-26-000013 · form4.xml · nonDerivative · entry 1

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,921,111

F1 · shares: Reflects performance-based restricted share units ("PSUs"), originally granted to the Reporting Person on March 2, 2023, which were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee of the Board of Directors of the Issuer of the level of achievement of the financial performance metrics applicable to the PSUs for the performance period from January 1, 2023 through December 31, 2025. The PSUs remain subject to a service-based vesting condition through March 2, 2026. Subject to the satisfaction by the Reporting Person of the service-based vesting condition, the Issuer will deliver to the Reporting Person the number of Common Shares earned based on achievement of the financial performance metrics as soon as administratively practicable thereafter.

SEC source: 0000885590-26-000011 · form4.xml · nonDerivative · entry 1

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 637,507

F1 · shares: Reflects performance-based restricted share units ("PSUs"), originally granted to the Reporting Person on March 2, 2023, which were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee of the Board of Directors of the Issuer of the level of achievement of the financial performance metrics applicable to the PSUs for the performance period from January 1, 2023 through December 31, 2025. The PSUs remain subject to a service-based vesting condition through March 2, 2026. Subject to the satisfaction by the Reporting Person of the service-based vesting condition, the Issuer will deliver to the Reporting Person the number of Common Shares earned based on achievement of the financial performance metrics as soon as administratively practicable thereafter.

SEC source: 0000885590-26-000003 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360,120

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000002 · form4.xml · nonDerivative · entry 1

LEUNG SANDRA · CIK 0001199294 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,408

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-26-000001 · form4.xml · nonDerivative · entry 1

WECHSLER AMY B · CIK 0001677300 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 266,441

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0001013594-25-001474 · form4.xml · nonDerivative · entry 1

PAULSON & CO. INC. · CIK 0001035674 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Managed Funds

Disclosed balance after: 73,255,869

F1 · ownership.direct: Paulson & Co. ("Paulson") is the investment manager of certain investment funds (the "Funds"). John Paulson is the controlling person of Paulson. All securities reported on this Form 4 are owned by the Funds. Each of Paulson and John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any securities not directly owned by such reporting person.

F1 · ownership.nature: Paulson & Co. ("Paulson") is the investment manager of certain investment funds (the "Funds"). John Paulson is the controlling person of Paulson. All securities reported on this Form 4 are owned by the Funds. Each of Paulson and John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any securities not directly owned by such reporting person.

SEC source: 0000885590-25-000038 · form4.xml · nonDerivative · entry 1

LEUNG SANDRA · CIK 0001199294 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,822

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.

SEC source: 0000885590-25-000039 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,128

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.